Spero Therapeutics Inc

NASDAQ:SPRO   10:32:06 AM EDT
14.02
-0.15 (-1.06%)
Earnings Announcements

Spero Therapeutics Posts Quarterly Loss Per Share Of $0.70

Published: 11/10/2021 22:23 GMT
Spero Therapeutics Inc (SPRO) - Spero Therapeutics Announces Third Quarter 2021 Operating Results and Provides Business Update.
Spero Therapeutics Inc Qtrly Loss per Share $0.70.
Revenue is expected to be $5.67 Million
Adjusted EPS is expected to be -$0.74

Next Quarter Revenue Guidance is expected to be $5 Million
Next Quarter EPS Guidance is expected to be -$1.06

More details on our Analysts Page.